EUVIMEDEUVIMED entdecken
Crossref

Development of Comprehensive Ultraperformance Liquid Chromatography–High-Resolution Mass Spectrometry Assays to Quantitate Cisplatin-Induced DNA–DNA Cross-Links

Arnold S Groehler, Asema Maratova, Nhat Mai Dao, Anuar Mahkmut, Orlando D Schärer iD

Chemical Research in Toxicology · 2023

DOI: 10.1021/acs.chemrestox.2c00308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2023. Verfasst von Arnold S Groehler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea. Hauptthemen laut MEDLINE: Cisplatin, DNA Adducts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Institute for Basic Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (CP) is a common antitumor drug that is used to treat many solid tumors. The activity of CP is attributed to the formation of DNA-DNA cross-links, which consist of 1,2-intra-, 1,3-intra-, and interstrand cross-links. To better understand how each intrastrand cross-link contributes to the activity of CP, we have developed comprehensive ultraperformance liquid chromatography-selective ion monitoring (UPLC-SIM) assays to quantify 1,2-GG-, 1,2-AG-, 1,3-GCG-, and 1,3-GTG-intrastrand cross-links. The limit of quantitation for the developed assays ranged from 5 to 50 fmol or as low as 6 cross-links per 108 nucleotides. To demonstrate the utility of the UPLC-SIM assays, we first performed in vitro cross-link formation kinetics experiments. We confirmed that the 1,2-GG-intrastrand cross-links were the most abundant intrastrand cross-link and formed at a faster rate compared to 1,2-AG- and 1,3-intrastrand cross-links. Furthermore, we investigated the repair kinetics of intrastrand cross-links in CP-treated wild-type and nucleotide excision repair (NER)-deficient U2OS cells. We observed a slow decrease of both 1,2- and 1,3-intrastrand cross-links in wild-type cells and no evidence of direct repair in the NER-deficient cells. Taken together, we have demonstrated that our assays are capable of accurately quantifying intrastrand cross-links in CP-treated samples and can be utilized to better understand the activity of CP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDNA AdductsDNAChromatography, LiquidMass SpectrometryDNA RepairCross-Linking Reagents

Substanzen

CisplatinDNA AdductsDNACross-Linking Reagents

Autor:innen und Institutionen

  • Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea.
  • Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
  • Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.

ORCID-Profile: Orlando D Schärer

Förderung

  • Institute for Basic Science

Zitieren

APA

Groehler, A. S., Maratova, A., Dao, N. M., Mahkmut, A., & Schärer, O. D. (2023). Development of Comprehensive Ultraperformance Liquid Chromatography–High-Resolution Mass Spectrometry Assays to Quantitate Cisplatin-Induced DNA–DNA Cross-Links. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.2c00308

Vancouver

Groehler AS, Maratova A, Dao NM, Mahkmut A, Schärer OD. Development of Comprehensive Ultraperformance Liquid Chromatography–High-Resolution Mass Spectrometry Assays to Quantitate Cisplatin-Induced DNA–DNA Cross-Links. Chemical Research in Toxicology. 2023. doi:10.1021/acs.chemrestox.2c00308

BibTeX
@article{Groehler2023,
  author = {Groehler, Arnold S and Maratova, Asema and Dao, Nhat Mai and Mahkmut, Anuar and Schärer, Orlando D},
  title = {Development of Comprehensive Ultraperformance Liquid Chromatography–High-Resolution Mass Spectrometry Assays to Quantitate Cisplatin-Induced DNA–DNA Cross-Links},
  journal = {Chemical Research in Toxicology},
  year = {2023},
  doi = {10.1021/acs.chemrestox.2c00308}
}
Kostenlos starten →